Header cover image

German Healthcare Undervalued based on future growth

Results

3

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

3 companies

Medios

Market Cap: €369.3m

Supplies specialty pharmaceutical drugs primarily in Germany.

ILM1

€14.48

7D

18.3%

1Y

0.8%

M1 Kliniken

Market Cap: €272.8m

Provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia.

M12

€14.70

7D

2.8%

1Y

-10.4%

Stratec

Market Cap: €259.5m

Provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally.

SBS

€21.35

7D

8.7%

1Y

-26.6%